Jun 23, 2020
Nobilis Therapeutics Announces IND Filing for a Phase 2b Clinical Trial of NBTX-001 Drug/Device Combination for Treatment of Panic Disorder
Jun 08, 2020
IDEAYA Announces Nomination of Development Candidate, IDE397, for MAT2A Synthetic Lethality Program Targeting MTAP-Deletion Patient Population
May 28, 2020
DURECT to Present at the Jefferies 2020 Virtual Health Care Conference
May 27, 2020
CNS Provides Update on Development Agreement for WP1122
May 27, 2020
Moleculin Provides Update on Coronavirus Drug Development
May 26, 2020
CytRx Corporation Highlights Orphazyme's Receipt of FDA Fast Track Designation for the Development of Arimoclomol in Amyotrophic Lateral Sclerosis (ALS)
May 11, 2020
Coronavirus (COVID-19) Update: FDA Takes New Actions to Accelerate Development of Novel Prevention, Treatment Options for COVID-19
May 05, 2020
Synthetic Biologics Reports 2020 First Quarter Operational Highlights and Financial Results
May 01, 2020
Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment
Apr 03, 2020
Coronavirus (COVID-19) Update: FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19
Apr 01, 2020
Vaccine for COVID-19 Health Crises "Possible" by Summer After FDA Fast-Tracks Clinical Trials
Mar 24, 2020
Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted
Mar 19, 2020
Coronavirus (COVID-19) Update: FDA Continues to Facilitate Development of Treatments
Feb 26, 2020
DURECT Corporation to Announce 2019 Financial Results on March 3
Jan 22, 2020
Biohaven's Verdiperstat Receives FDA May Proceed Letter To Initiate Trial In Amyotrophic Lateral Sclerosis Conducted By The Healey Center For ALS At Mass General
Jan 09, 2020
Presage Receives FDA Clearance of First IND Application for Trial to Evaluate Investigational Oncology Agents with CIVO(TM) Technology
Jan 01, 2020
WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392
Nov 11, 2019
MabPlex Congratulates Encure Biopharma with FDA IND Clearance of YH001 for the Treatment of a Broad Range of Cancers
Nov 04, 2019
Synthetic Biologics Reports Third Quarter 2019 Operational Highlights and Financial Results
Oct 30, 2019
Biostage Submits Investigational New Drug (IND) Application for Lead Product Candidate Cellspan(TM) Esophageal Implant for Treatment of Esophageal Conditions